GPT-5 and Automated Labs Slash Cell-Free Protein Synthesis Costs by 40%, Ushering in a New Era of Biotech Innovation
A groundbreaking collaboration between OpenAI and Ginkgo Bioworks has yielded a dramatic breakthrough in biotechnology. By integrating GPT-5 with cloud-based automation, researchers have achieved a 40% reduction in the cost of cell-free protein synthesis, paving the way for faster and cheaper drug discovery and biomanufacturing.

![Apple's Q[Current Year] Earnings: Chip Shortages Bite, Chinese Demand Remains Strong Amid Design Shifts](https://i0.wp.com/stratechery.com/wp-content/uploads/2026/02/apple-earnings-1.png?fit=1200%2C807&ssl=1)





